INTRODUCTION
Cows' milk and milk products are a part of our diet from birth and, although there is no evidence that milk contains prions, there has been much debate over its continued use when sourced from animals potentially incubating bovine spongiform encephalopathy (BSE), the cattle prion disease. Epidemiological studies have revealed a maternally enhanced risk of BSE transmission to calves of BSE-affected cows. The size of that risk is associated with the stage of the disease in the dam at the time of calving (Curnow & Hau, 1996; Donnelly et al., 1997; Ferguson et al., 1997a, b; Wilesmith & Ryan, 1997) . Donnelly et al. (1997) showed an enhanced risk of BSE infection in calves born to infected dams within 24 months of onset of clinical BSE. If transmitted from the dam, such infection might arise in utero, in the immediate post-parturition period or by vertical transmission to the calf (Wilesmith et al., 1992; Winter et al., 1989) ; hence, suckling milk and/or colostrum are possible vehicles for transmission from cow to calf.
Colostrum is a low-volume, protein-rich fluid taken by calves soon after birth at a time (up to 48 h) when absorption of whole proteins from the gut is enabled (Matte et al., 1982; Quigley & Drewry, 1998) . Bovine colostrum is not normally part of the human diet. Calves born in a dairy herd normally receive only colostrum for 24-48 h after birth, and reconstituted milk replacer, but no milk, thereafter, whereas calves in a suckler herd commonly receive both colostrum (for up to 48 h) and the dam's milk for extended periods (up to 6 months). Data from a suckler-herd study in the UK indicated no evidence of BSE in offspring born to BSE-infected cows (Wilesmith & Ryan, 1997) . This argues against consumption of milk or colostrum from BSEinfected cows as a risk factor for intraspecies transmission of BSE [but see the paper by Donnelly et al. (1997) ]. Similarly, in other transmissible spongiform encephalopathy (TSE) diseases, evidence for infectivity in milk or colostrum is negligible.
There is also no direct evidence from past experimental studies for the presence of infectious TSE agent in milk, although, for logistical reasons, the volumes and number of samples examined have been very limited. These have included the intracerebral (i.c.) (0?02 ml, single inoculation), intraperitoneal (i.p.) (0?1 ml, single inoculation) and oral (300 ml over 40 days) dosing of mice with milk collected at early-, mid-and late-lactation points from BSEinfected cows that subsequently developed disease (Bradley, 1993; Taylor et al., 1995) . Milk and udder tissue from four cases of terminal-disease bovine BSE were fed to mice (Middleton & Barlow, 1993 ) at a level of 14?6 ml and 128?9 g (C57Bl mice) and 20?2 ml and 144 g (CRH mice) over a period of 27 days with no evidence of infection. Reports of transmission of disease to mice by i.c. inoculation of human colostrum from a woman with preclinical sporadic CJD (Tamai et al., 1992) have not been confirmed.
In late 1999, several rapid tests for the confirmatory diagnosis of BSE using bovine brain homogenates became available (Moynagh & Schimmel, 1999) . These tests are based on the detection of abnormal prion protein (PrP BSE ), a marker for TSE infectivity. One, the Bio-Rad Platelia, was claimed to have an analytical sensitivity for PrP BSE equivalent to that of the mouse bioassay for BSE infectivity (Grassi et al., 2001; Moynagh & Schimmel, 1999) . The mouse bioassay, using i.c. and i.p. inoculations, is very timeconsuming and can only test for infectivity in a very limited volume of milk; therefore, it was decided to validate this type of rapid screening test for PrP BSE and apply it to milk samples. The results would then provide further data required for a quantitative assessment of risk of BSE transmission via milk.
The validation of a milk prion assay in the absence of a positive control, that is, a naturally 'infectious' milk specimen, poses several problems relating to the classification of a positive result. In order to determine defined levels of confidence that a 'positive' result was a chance false-positive rather than a true-positive result, thousands of true-negative samples would require analysis. Alternatively, a second test based on an independent physicochemical principle could be designed to confirm 'reactives' as true negative or positives. The latter approach was adopted within this study.
The specificity of the Bio-Rad Platelia for PrP BSE rather than PrP C relies on the relative resistance of the abnormal protein to proteinase K (PK) hydrolysis under mild denaturing conditions. The confirmatory test developed hence excluded proteinases and instead achieved this specificity by physical adsorption of aggregates of PrP BSE to a polyanionic ligand, the Seprion reagent (Microsens Biotechnologies), followed by elution and detection by a PrP immunoblot system. This has the advantage that ligands selective for abnormal PrP, such as the Seprion polymer or the 15B3 mAb (Korth et al.,1997) , may also bind proteinasesensitive, infection-related forms of PrP (Nazor et al., 2005) .
The quantitative assessment of risk of BSE transmission to humans via milk requires that the limit of detection of the screening and confirmatory tests for abnormal BSE prion protein needs to be calibrated against an infectivity titre. In the absence of an 'infectious' milk control, the VLA 'pathogenesis' study provides the most appropriate data for calibration and is accrued from experiments where cattle were fed dilutions of infected cattle-brain homogenate (Wells et al., 1994 (Wells et al., , 1996 (Wells et al., , 1998 (Wells et al., , 1999 . Similar (but not identical) homogenates from clinical, confirmed cases of BSE were used to produce dilution curves from which limits of detection in mg equivalents of cattle brain were derived and converted into cattle oral ID 50 (CoID 50 ) units.
Cows' milk is mostly water (87?4 %), a complex colloidal dispersion of fat (3?7 %), caseins (2?7 %), whey proteins (0?7 %), lactose (4?8 %) and minerals (0?7 %) and a variable amount of somatic cells, cell fragments and bacteria (Jensen, 1995) . Abnormal PrP and infectivity co-partition with cells and membrane sheets during the fractionation of brain tissue in the absence of detergents so, assuming that any abnormal PrP in milk would be similarly associated with cells, we adapted the commercially available rapid BSE test to detect PrP BSE brain homogenates or detergent extracts spiked into a milk-cell concentrate and applied this screening test to similar milk fractions sourced from BSEchallenged cattle and control animals.
METHODS
Milk collection, storage and processing. Milk specimens were collected from groups of lactating female cattle (10 animals per group) challenged orally at 4-6 months of age with 100 or 1 g BSE brain homogenate or from unchallenged, age-matched control animals sourced from the same herds and kept in the same environment. The design of this dosing scheme was based on previous oral 'pathogenesis' studies (Wells et al., 1994 (Wells et al., , 1996 (Wells et al., , 1998 (Wells et al., , 1999 . Infection was subsequently confirmed in the high dose-challenged milk donors by observation of clinical signs (in all but one animal that was culled because of mastitis) and final histopathological examination of brain tissue at necropsy (Wells et al., 1998) . No BSE has been observed at any stage in the surviving control (n=8) or low dose-challenged animals (n=8), nor at necropsy of intercurrent kills (n=2 for both the control and low-dose groups).
The cows first calved at an age of between 2 and 3 years and each of the three groups were housed and managed separately with no contact between groups, which had completely separate husbandry regimes. Cows in the high-dose group survived to provide milk from only one or two pregnancies before showing the clinical signs of BSE, whilst the low-dose and control animals have survived longer and have been inseminated, calved and milked for up to four lactations. For each lactation, up to 10 l milk was collected at each of five time points postcalving: 0-7 days and at 10, 20, 30 and, when possible, 40 weeks.
During this experiment, there were bouts of mastitis in 20 cows from within all three groups and all four lactation periods; these observations were recorded here because of the possible confounding effect of concurrent inflammatory disease on the tissue distribution of infectivity in TSE-infected animals Seeger et al., 2005) .
Milk was stored at 4 uC and subsequently centrifuged at 500 g for 2 h at 4 uC. The cream and liquid milk were removed, ensuring that all of the cell sediment was retained. Each 1 l equivalent of this cellular fraction was resuspended in PBS (12 ml, 0?05 M, pH 7?4) and stored at 220 uC. These cell concentrates were thawed at 4 uC for 16 h prior to use. The mean dry-weight analysis of this resuspended sediment was 0?038 mg ml 21 (range, 0?0014-0?3580 mg ml 21 ).
Prion protein (PrP) ELISA. The Bio-Rad Platelia 'purification kit' and 'detection kit' provided the reagents for the extraction and PK hydrolysis of abnormal prion protein (PrP BSE ) and the subsequent detection of residual PrP, PrP res , by a sandwich ELISA. This set of reagents allows the solubilization of tissue or cell extracts in a homogenization buffer (A), the controlled digestion of proteins, including normal cellular prion protein (PrP C ), by low concentrations of PK (<10 mg ml 21 ) in buffer A, alcohol (buffer B) precipitation of residual proteins including PrP res , denaturation (in buffer C1) and solubilization of the precipitate and dilution (in buffer R6) for assay using a two-mAb (one for capture and one for detection) microtitre plate-based colorimetric immunoassay. By changing the volumes specified by the manufacturer, this protocol was adapted to detect total PrP (no PK-digestion step included) or PrP res (PK added) in BSE-affected brain homogenate-spiked milk-cell samples, BSEspiked normal bovine-brain homogenates or unaffected brainhomogenate-spiked milk-cell samples.
Briefly, resuspended milk-sediment sample (0?875 ml) was added to an equal volume of Bio-Rad homogenization buffer (A) and agitated by using a vibration homogenizer (Ribolyser; Hybaid). Equal volumes (0?5 ml) of this milk extract (ME) and Bio-Rad buffer A, with or without PK, were mixed and incubated at 37 uC for 10 min before alcohol precipitation with buffer B (0?5 ml) and centrifugation at 15 000 g for 7 min at 20 uC. After centrifugation, the supernatant was removed, buffer C1 (0?2 ml) was added to the pellet and incubated at 100 uC for 5 min, followed by dilution with buffer R6 (0?5 ml). Milk-cell controls, negative and positive (spiked) milk controls and all milk test samples were then assayed by using the microtitre-well system (0?1 ml final sample extract per well). This represents the milk solids from the equivalent of approximately 3 ml whole milk per well.
Bovine-brain pools. BSE-positive bovine brain, a mixture of spinal cord (C1-C2), medulla and cerebellum, was liquidized on ice and its volume was adjusted with deionized water to prepare a standard pool of 20 % (w/v). This positive-control pool and a similar negative standard prepared from BSE-negative brain tissue were aliquotted and stored at 280 uC prior to use. These pools are referred to as positive (+) and negative (2) 20 % (w/v) bovine-brain standards, respectively.
ELISA standards, analytical sensitivity and the effects of milk. Serial dilutions of the 20 % (w/v) BSE-positive bovine-brain standard were prepared in 20 % (w/v) non-BSE-infected bovinebrain homogenate. A 0?5 ml aliquot of each dilution was then mixed with an equal volume of Bio-Rad buffer A, with or without PK, and processed for assay as described above. To assess the effect of milk components on this dose-response curve, an ELISA positive-spiked control milk standard curve was prepared by combining each brainhomogenate dilution (0?1 ml) with 0?4 ml ME, mixing with an equal volume of Bio-Rad buffer A, with or without PK, and processing these samples similarly for assay.
Analysis of the milk-cell fractions. Individual milk-residue samples were analysed initially by using the adapted Bio-Rad Platelia assay. Those found to be >3SD from the mean of the negative controls were deemed 'reactive' and were retested by using the same procedure, but surrounded by different control samples on the plate.
Determination of final test-reactive results employed a calculation of the mean absolute deviation (MAD) (Miller & Miller, 2000) . The MAD was derived by first calculating the median of all of the data, then calculating the absolute difference of each observation in the whole dataset from this median: this is the difference without regard as to whether it is positive or negative, above or below the median. Finally, the median of this set of differences was calculated to give an estimate SD of the data, with the cut-off set as 3SD of this value above the new median. The final set of reactive samples was determined by using a cut-off calculated from the whole dataset or a cut-off calculated separately for each lactation.
Seprion-PAGE/Western blot analysis of milk cellular fractions. Milk concentrate (ME) samples (0?41 ml), unspiked or spiked with serial dilutions of the 20 % (w/v) BSE-positive bovine-brain standard prepared in 20 % (w/v) non-BSE-infected bovine-brain homogenate, were added to Bio-Rad Platelia 'purification kit' homogenization buffer (2?70 ml) and homogenized by vibration. This diluted milk sample (2?35 ml) was mixed with 600 ml Seprion capture buffer (Microsens Biotechnologies), Seprion-coated magnetic beads (0?05 ml) were added and the mixture was rotated at 60 uC for 16 h. The sample tubes were then placed in magnetic racks (Dynal Biotech) to fix the bound PrP BSE -magnetic-bead complex and washed four times with Bio-Rad Platelia wash buffer. After a final rinse in deionized water, the complex was dissociated by heating at 100 uC for 10 min in SDS-PAGE sample buffer (0?045 ml) (Prionics-Check Western Blot kit) and the denatured proteins in the extract (0?015 ml) were analysed by SDS-PAGE/Western blot using the 6H4 mAb as detector according to the Prionics-Check Western Blot kit protocol. The equivalent of 8?6 ml whole milk was analysed per track.
RESULTS AND DISCUSSION

Adaptation of the Bio-Rad Platelia
The Bio-Rad Platelia system was adapted in order to allow the use of milk and milk residues spiked with bovine-brain homogenate to be assayed. Dose-response curves of serial dilutions of (+)-bovine standard spiked into (2)-bovine standard or milk-cell residue are shown in Fig. 1 and indicate that the levels of milk fat and milk proteins used in the screening part of this evaluation do not affect the analytical sensitivity of this adapted assay significantly, compared with its sensitivity applied to bovine-brain homogenate.
Estimating the sensitivity of the ELISA in CoID 50 units
Estimates of the titre of infectivity in homogenates of cattle central nervous system tissue sourced from clinical, confirmed cases of BSE have been made from the oralchallenge studies from which the high-and low-dose challenge groups of milk donors in these experiments were selected. These VLA 'attack-rate' studies are incomplete, but a median value of 0?58 [95 % confidence interval Wells, personal communication) . This estimate of titre has been applied to the homogenate of BSE-infected bovine brain used as a standard in our ELISA and Western blot systems, although this titre was not measured directly on this material. From the ELISA dose-response curves for dilutions of BSEinfected brain homogenate in milk-cell fractions using the PK protocol, a limit of detection equivalent to 0?31 mg brain tissue and, using the non-PK protocol, a limit of detection of 0?09 mg can be derived (Fig. 2) . A working estimate of 0?25 mg brain was taken as a reasonable composite of the two disparate assay formats in order to prevent the necessity of two separate calculations. In each well of the ELISA, there is the equivalent of 3 ml whole milk and so, assuming that the recovery of sample is 100 %, the limit of detection of BSE infectivity in 1 l whole milk would be 0?14 (C.I., 0?0013-0?21) CoLD 50 l
21
. In each track of that Seprion/Western blot, there is the equivalent of milk solids from 8?6 ml whole milk and so, again assuming that the recovery of sample is 100 %, the limit of detection of BSE infectivity in 1 l whole milk is 0?05 (C.I., 0?0005-0?0725) CoLD 50 l
.
Milk
Identification of 'reactive' milk samples: statistical methods. The combined ELISA absorbance data of the milk and colostrum samples from all three groups of cattle are shown in Fig. 3 , segregated according to lactation cycle and PK treatment. The effective limit of detection for the assay process, and the subsequent identification of outliers as test-'reactive' samples, was determined by a statistical analysis of these milk/colostrum screening data. The critical value of deviation of a suspect value from the sample population mean is usually accepted as 3SD for datasets of 40 or more and was essentially the process employed to determine which individual milk sample would be retested by the Bio-Rad Platelia method. This process requires that the data arise from a fundamentally Gaussian distribution and relies on the value of the mean and median being identical and on the SD being determined as a multiple (>1?5-fold) of the MAD of the data. Neither the median nor the MAD is affected much by a reasonable number of outlying observations, allowing calculation of an appropriate cut-off value relative to the assumed underlying Gaussian distribution and, hence, definition of a population of test 'reactives'.
The MAD has been derived by first calculating the median of all of the data, followed by calculating the absolute difference of each observation in the whole dataset from this median and finally taking the median of this set of differences. The MAD was then taken and multiplied by 4?5 (=1?563) and the result was added to the median of the data, giving a robust estimate of the mean +3SD of the population. All specimens with values above this were deemed 'reactive'. Those with values below this cut-off were regarded as negative within the limits of sensitivity.
Identification of 'reactive' milk samples: lactationspecific cut-offs. Twenty-two of the 541 cattle-milk sam- Fig. 2 . Comparative sensitivity of the Seprion extraction/Western blot (&, dashed line) and the Bio-Rad Platelia ELISA applied with (., dashed line) or without (#, solid line) inclusion of its PK-hydrolysis step. For each curve, two dilution series of (i) BSE-positiveand (ii) BSE-negative-brain-spiked samples of milk-sediment preparations were assayed and each curve point value was calculated as the difference of value (i) " value (ii). Vertical arrows indicate the respective assay cut-off value of a positive result, determined as the mean+3SD of a set of authentic negative tissue samples.
ples were classed as 'reactive' following MAD analysis of their assay data from the adapted Bio-Rad Platelia procedure with or without the inclusion of PK (Table 1) . However, differences existed between the median absorbance values of different lactation cycles and also of the samples taken 1 week post-calving. Therefore, the data were reanalysed by MAD analysis applied to each lactation period separately, giving different cut-off points for each period and for the week 1 post-calving values (Fig. 3) . By this procedure, six new samples were recorded as 'reactive' in one or both of the duplicate wells. These samples are highlighted in Table 1 . As would be expected for random variation, in this reanalysis, about half of the assays were made more sensitive and half less sensitive relative to a cut-off derived from the whole population of results.
No association between 'reactivity' and TSE
In all, eight milk specimens from five individual animals were identified as 'reactive' from the unchallenged animals, 14 from seven individual animals in the low dose-challenged group and six from four individual animals in the high dose-challenged group by at least one of the ELISA assays (Table 1; Fig. 3) . The number of different animals sampled to provide specimens varied with each group for operational reasons. In total, 80 specimens were sampled from unchallenged animals, 90 specimens from low dose-challenged animals and 49 specimens from the high dose-challenged animals. Six of these specimens proved 'reactive' by using both the PK and non-PK ELISA protocols; significantly, these specimens were all collected from different cows in the first week post-calving: three from the unchallenged group in their first, second and third lactations, respectively, and three from the low dose-challenged group in their third (n=2) or fourth (n=1) lactation (Table 1) . One specimen from animal No. 276 from the low-dose group proved 'reactive' only in the PK ELISA.
Searching through the data for other associations with 'reactivity' was less fruitful. From the unchallenged group, five of the 10 cows provided the eight milk specimens that were reactive in the Bio-Rad Platelia screening test, with one cow (No. 1) providing four specimens. Five samples were obtained within the first week post-calving from lactation periods 1-4, two from the 20 week post-calving period in lactations 3 and 4 and one from the 40 week collection from lactation 1. The low-dose group provided seven cows with 14 reactive specimens, which included nine samples from the first week post-calving from lactations 1-4 and one each from the 40 weeks lactation 1, 30 weeks lactation 2 and 10, 20 and 30 weeks periods from lactation 4. The high dosechallenged group saw fewer 'reactives' overall, with four individual cows producing six 'reactive' milk samples, five of which were first-week collections from lactation periods 1-3 Fig. 3 . Scatter plot of Bio-Rad Platelia ELISA absorbance values for milk and colostrum samples. The data for all three groups of cattle -high-dose, low-dose and controls -have been combined and presented for each lactation period (x axis, 1-4) segregated into (from left to right of each lactation period) milk (+PK, X), milk ("PK, n), colostrum (+PK, $) and colostrum ("PK, %). The base of the filled triangle to the left of each set of data represents the median value, and the black bar the mean absolute deviation (MAD) cut-off value, for each dataset. Each point represents the mean of two absorbance measurements per sample.
and one at 20 weeks in the second lactation cycle. PK is used routinely in TSE screening tests to discriminate between the normal and abnormal isoforms of the prion protein, but several samples from both the unchallenged and low-dose groups and none from the high-dose group gave 'reactives' by using the PK ELISA protocol and, so, we conclude that there was no correlation between BSE challenge/disease status and test 'reactivity'.
No association between 'reactivity' and mastitis
Mastitis is a common disease in dairy herds. Macrophage and polymorphonuclear leukocytes or neutrophils predominate in both milk and colostrum, whilst lymphocytes constitute up to 15 % of the total leukocyte population. Recently, the presence of chronic lymphocytic inflammation has been shown to facilitate ectopic PrP Sc accumulation, raising the possibility that the udder may be a site of prion propagation in inflammatory conditions such as mastitis Seeger et al., 2005) . Indeed, Ligios et al. (2005) have now observed PrP Sc in the mammary gland of sheep suffering from mastitis.
In this study, we recorded many cases of mastitis in all three groups of milk donors. However, we were unable to find any evidence that mastitis stimulates replication of abnormal Table 1 . List of 'reactive' samples according to median absolute deviation (MAD)-derived cut-off points for the Bio-Rad Platelia screening ELISA Challenge status: high dose, 100 g BSE brain; low dose, 1?0 g BSE brain. The specimens highlighted in bold were identified by using lactation-specific cut-off values.
prions in the udder under conditions thought to mimic the natural oral BSE infection. Only one animal (of 10) (No. 133) was reactive (at lactation 2) and had a recorded bout of mastitis (during its first lactation) in the high-dose group, although all of the cattle (5/10) in the unchallenged group displaying reactive results suffered from periodic bouts of mastitis and six of the seven reactive (of 10) cows in the low dose-challenged group also had at least one incidence of mastitis. These data and their statistical analysis are summarized in Table 3 .
Further investigation of the Bio-Rad milk 'reactives' Statistically, very large numbers of known negative samples are required to demonstrate a high level of specificity with an acceptable degree of confidence and, unless the specificity of a test is extremely high, there is a non-negligible probability of obtaining a false-positive result. Therefore, to have a high confidence that a 'reactive' reflects a true-positive sample, thousands of known negative samples would need to be analysed in a validation process. As this was not practically feasible, the specificity of the analytical process was increased by applying two independent but complementary assays and accepting as positive only those samples that were reactive in both tests. This would be likely to result in a loss in overall sensitivity unless the two tests have similar sensitivity. We therefore developed an independent, confirmatory assay of comparable analytical sensitivity in order to investigate further the Bio-Rad milk 'reactives'.
Development of a confirmatory test: Seprion-PAGE/Western blot analysis
The method that we developed uses a charged polymer (the Seprion ligand) to extract abnormal prion protein from solution, followed by denaturation of the bound PrP BSE and SDS-PAGE/immunoblot analysis. The Seprion technology uses synthetic polymers that bind PrP Sc specifically in the presence of PrP C (Lane et al., 2003) . Capture is via polyionic interaction between the chemical ligand and PrP Sc and requires an ionic surfactant to competitively inhibit any weak binding of PrP C . The selectivity of the Seprion-ligand capture technology eliminates the need for PK digestion to remove PrP C and hence distinguishes this protocol from those PrP BSE -diagnostic methods that rely on PK hydrolysis of PrP C for their specificity. The specificity and sensitivity of the Seprion technology are demonstrated in Fig. 2 , where the sensitivity of the Western blot and the ELISA is compared. Abnormal PrP was extracted from samples by using the Seprion polymer, denatured, separated by SDS-PAGE and visualized by Western blot using mAb 6H4. In the initial characterization studies, no banding was observed in 12 individual ME samples from unchallenged cattle and from pooled MEs derived from milk collected at weeks 10, 20 and 30 from unchallenged cattle by this Seprion/Western immunoblot technique. In addition, all milk samples spiked with BSE-negative brain homogenate remained negative for immunoreactive staining at 30 kDa, whilst there was a dose-response effect for the milk samples spiked with increasing amounts of BSE-infected brain standards.
Application of the confirmatory test
Of the 28 individual samples found to be reactive by using the Bio-Rad ELISA (Table 1) , 12 gave positive band signals by using the Seprion/Western blot method ( Table 2 ). All of these 'positives' were colostrum samples collected within 1 week of calving, irrespective of challenge group. Immunoreactive bands in the molecular mass ranges of >80 kDa (HMM band), 25-29 kDa and 20-22 kDa were observed and one or more of these bands was seen in each sample (Fig. 4) . Twenty-two bands from eight cases, including all HMM and 25-29 kDa bands, were still observed when the primary mAb (6H4) was omitted from the method protocol. Changing the secondary-antibody detection conjugate failed to improve on this lack of specificity and we conclude that the majority, if not all, of these signals are due to crossreactions between the secondary antibody and proteins (possibly immunoglobulins) present in the samples taken in the first week post-calving.
In conclusion, no abnormal prion protein has so far been identified in the cellular fraction of milk from cattle incubating BSE by using these methods at their limits of detection. This agrees with the work of Castilla et al. (2005) , involving the experimental infection of a transgenic mouse line expressing bovine PrP (boTg) with BSE prions administered i.c. These authors demonstrated that vertical transmission occurred when mating took place close to the clinical stage of the disease. In order to ascertain whether the feeding of milk was a possible route of infection, a volume of delipidated milk, equivalent to 25 % of the offspring's Table 2 . Bio-Rad Platelia 'reactive' milk samples that gave mAb 6H4-reactive bands signals following Seprion extraction and Western blotting All 'reactive' milk samples were from the first week post-calving.
Sample identification
Lactation No. 1  1  11  3  93  2  High dose  116  1  121  2  122  1  133  2  Low dose  256  3  269  3  270  2  276  1  281  4 intake during lactancy (the period during which the cow is lactating), was injected i.c. into boTg110 mice. Analysis of survival times failed to show any significant differences as a result of the inoculations and the histology and immunohistochemistry of the brains failed to detect any PrP res . Additionally, colostrum from a BSE-affected cow failed to transmit infection (monitored by subpassage) or disease after i.c. inoculation into another transgenic mouse overexpressing the bovine prion protein gene; although the volume of liquid administered was understandably small, this tgbovXV line has been estimated to be 10-fold more sensitive to BSE exposure than cattle (Buschmann & Groschup, 2005) .
Unchallenged
Throughout our study, no abnormal prion protein was identified in the cellular fraction of milk from cattle incubating BSE by using these biochemical methods at their limits of detection. Whilst this does not exclude milk as being a potential vehicle for the transmission of prions, it does concur with our current understanding of the pathogenesis of BSE. Infectivity in lymphoid tissue has only been found in the distal ileum (Wells et al., 1998; Terry et al., 2003) and the palatine tonsil of the tongue (Wells et al., 2005) , and non-neural involvement in BSE is relatively low, lessening the risk of infectivity in inflamed tissues with ectopic lymphoid follicles and its secretion in milk. Milk samples were taken in the first week post-calving from unchallenged cows (here numbered arbitrarily) at different lactation cycles and analysed in duplicate in adjacent lanes as follows: cow 1, lactation 4 (lanes 5 and 6); cow 2, lactation 1 (lanes 7 and 8); cow 3, lactation 1 (lanes 9 and 10); cow 4, lactation 3 (11 and 12); cow 5, lactation 2 (13 and 14). The mastitis/reactive results are summarized for each dose group. The entries are the number of animals. The possible differences between the tables were tested by the homogeneity of odds ratios test. This did not reject the hypothesis that the odds ratios were the same across the three tables (P=0?095). The common odds ratio was estimated as 0?577 and, as its 95 % C.I., 0?111-2?910, includes unity, there is no evidence of an association between an animal having mastitis and producing a reactive milk sample. 
Group
